Q: Hi
Normal volume is about 900,000/ day, today, Jan. 23, volume spiked to over 17 million shares. I can not find any news, any thing at your end?
Thanks
Q: Any specific reason why Birchcliff is down over 12% today, substantially more than its peers? Would note that Scotiabank provided a fairly positive report today on the company’s current status and 5-year operational plan. Thanks.
Q: What are your thoughts on HWO as far as an investment for a contrarian play with a large dividend and a loss of 50% in the last year. Where do you see them going in the next 12 months , any tailwinds on the horizon and is the fat dividend safe?
Thanx Gary
Q: I have had a small position in Keyera since before the oil price crash. It is still down 20% and even the most optimistic forecasts will only bring it close to my cost price. Its dividend is about the same at PPL, is lower than ENB and higher than TRP. ENB is my only other pipeline stock. I could sell KEY and add to ENB or open an position in PPL or TCP. Which do you think would be better for income and a little growth?
I'd like to add some names in the energy space given its beat up status. Can you provide 3 names that would provide a proxy on a recovery in this area?
Q: I currently have AQN (2.5%), BEP (1.5%) and INE (1%) and would like to add a further 1.5% overall to the "green" utility sector of my portfolio. Do you feel that BLX would be a good addition?
If so, I am thinking of adding .5% to BEP (to bring it to 2%) and 1% to BLX and wanted to get your thoughts for a +/-5 year hold.
Thanks!
Q: There is some selling today with the recent financing announcement, this name has been a bit of a darling of late, would you step in here? Whenever takeovers come up MEG always seems to be mentioned. Thanks.
Q: An y chance that ENB could benefit directly or indirectly from the Court's decision to allow
PPL to transit of fuel through BC to the coast?? or is better to invest in PPL??
Art
Q: Hello, I bought arx at 8.96 some time ago and now wondering if adding to the position would be advisable? It is below my cost and has positive analyst recommendations. Thank you.